Three Analyst Firms Start Greenway (GWAY) at Buy, Two at Neutral
Get Alerts GWAY Hot Sheet
Price: $20.35 --0%
Rating Summary:
0 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
0 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
A number of analyst firms have initiated coverage on shares of Greenway Medical Tech (NYSE: GWAY) Tuesday morning:
- Morgan Stanley with an Equalweight rating
- JPMorgan with an Overweight and $19 price target
- Piper Jaffray with a Neutral and $15 target
- William Blair with an Outperform
- Raymond James with an Outperform rating and a $17.50 target
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- Montrose Environmental (MEG) Announces Pricing of Public Offering of Shares
- Biogen (BIIB) tops earnings expectations but revenue falls short
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray, William Blair, JPMorgan, Raymond James, Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!